Halahleh, K. et al. 2025. Ruxolitinib Plus Extracorporeal Photopheresis for Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease. Journal of Clinical Medicine Research. 17, 12 (Jan. 2025), 698–707. DOI:https://doi.org/10.14740/jocmr6385.